Track insider transactions across markets
| 30 days | 90 days | 120 days | |
|---|---|---|---|
| Average return | 24% | 8.2% | 15.1% |
| Success rate | 62% | 68% | 82% |
| Transactions |
9
0% Buy
|
34
71% Buy
|
47
69% Buy
|
| Position | Company | Period |
|---|---|---|
| Chief Financial Officer | EyeGate Pharmaceuticals Inc | March 2, 2018 - |
| Interim Chief Financial Officer, Corporate Controller | EyeGate Pharmaceuticals Inc | Feb. 1, 2017 - Jan. 1, 2018 |
Search